G Quote, Financials, Valuation and Earnings

Concentrix has a net margin of 10.77% compared to Genpact's net margin of 1.74%. Genpact's return on equity of 22.22% beat Concentrix's return on equity of 5.94%.

Genpact has a consensus price target of $51.48, signalling upside risk potential of 14.47%. On the other hand Concentrix has an analysts' consensus of $67.67 which suggests that it could grow by 20.34%. Given that Concentrix has higher upside potential than Genpact, analysts believe Concentrix is more attractive than Genpact.

Genpact has a beta of 0.937, which suggesting that the stock is 6.337% less volatile than S&P 500. In comparison Concentrix has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Genpact has a quarterly dividend of $0.17 per share corresponding to a yield of 1.43%. Concentrix offers a yield of 2.31% to investors and pays a quarterly dividend of $0.33 per share. Genpact pays 21.12% of its earnings as a dividend. Concentrix pays out 33.36% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Genpact quarterly revenues are $1.2B, which are smaller than Concentrix quarterly revenues of $2.4B. Genpact's net income of $130.9M is higher than Concentrix's net income of $42.1M. Notably, Genpact's price-to-earnings ratio is 15.35x while Concentrix's PE ratio is 15.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genpact is 1.66x versus 0.37x for Concentrix. Usually stocks with elevated PS ratios are considered overvalued.

DXC Technology has a net margin of 10.77% compared to Genpact's net margin of 8.33%. Genpact's return on equity of 22.22% beat DXC Technology's return on equity of 12.05%.

Genpact has a consensus price target of $51.48, signalling upside risk potential of 14.47%. On the other hand DXC Technology has an analysts' consensus of $17.29 which suggests that it could grow by 8.59%. Given that Genpact has higher upside potential than DXC Technology, analysts believe Genpact is more attractive than DXC Technology.

Genpact has a beta of 0.937, which suggesting that the stock is 6.337% less volatile than S&P 500. In comparison DXC Technology has a beta of 1.197, suggesting its more volatile than the S&P 500 by 19.748%.

Genpact has a quarterly dividend of $0.17 per share corresponding to a yield of 1.43%. DXC Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Genpact pays 21.12% of its earnings as a dividend. DXC Technology pays out -- of its earnings as a dividend. Genpact's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Genpact quarterly revenues are $1.2B, which are smaller than DXC Technology quarterly revenues of $3.2B. Genpact's net income of $130.9M is lower than DXC Technology's net income of $264M. Notably, Genpact's price-to-earnings ratio is 15.35x while DXC Technology's PE ratio is 7.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genpact is 1.66x versus 0.23x for DXC Technology. Usually stocks with elevated PS ratios are considered overvalued.

StoneCo has a net margin of 10.77% compared to Genpact's net margin of 14.78%. Genpact's return on equity of 22.22% beat StoneCo's return on equity of -8.83%.

Genpact has a consensus price target of $51.48, signalling upside risk potential of 14.47%. On the other hand StoneCo has an analysts' consensus of $16.73 which suggests that it could grow by 3.66%. Given that Genpact has higher upside potential than StoneCo, analysts believe Genpact is more attractive than StoneCo.

Genpact has a beta of 0.937, which suggesting that the stock is 6.337% less volatile than S&P 500. In comparison StoneCo has a beta of 1.942, suggesting its more volatile than the S&P 500 by 94.229%.

Genpact has a quarterly dividend of $0.17 per share corresponding to a yield of 1.43%. StoneCo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Genpact pays 21.12% of its earnings as a dividend. StoneCo pays out -- of its earnings as a dividend. Genpact's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Genpact quarterly revenues are $1.2B, which are larger than StoneCo quarterly revenues of $593.7M. Genpact's net income of $130.9M is higher than StoneCo's net income of $87.8M. Notably, Genpact's price-to-earnings ratio is 15.35x while StoneCo's PE ratio is 7.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genpact is 1.66x versus 2.04x for StoneCo. Usually stocks with elevated PS ratios are considered overvalued.

TaskUs has a net margin of 10.77% compared to Genpact's net margin of 7.61%. Genpact's return on equity of 22.22% beat TaskUs's return on equity of 11.42%.

Genpact has a consensus price target of $51.48, signalling upside risk potential of 14.47%. On the other hand TaskUs has an analysts' consensus of $17.75 which suggests that it could grow by 6.1%. Given that Genpact has higher upside potential than TaskUs, analysts believe Genpact is more attractive than TaskUs.

Genpact has a beta of 0.937, which suggesting that the stock is 6.337% less volatile than S&P 500. In comparison TaskUs has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Genpact has a quarterly dividend of $0.17 per share corresponding to a yield of 1.43%. TaskUs offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Genpact pays 21.12% of its earnings as a dividend. TaskUs pays out -- of its earnings as a dividend. Genpact's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Genpact quarterly revenues are $1.2B, which are larger than TaskUs quarterly revenues of $277.8M. Genpact's net income of $130.9M is higher than TaskUs's net income of $21.1M. Notably, Genpact's price-to-earnings ratio is 15.35x while TaskUs's PE ratio is 27.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genpact is 1.66x versus 1.48x for TaskUs. Usually stocks with elevated PS ratios are considered overvalued.